Join
Live feed
·
PRReleasevia Quantisnow
BioCryst Pharmaceuticals Inc. logo
Royalty Pharma plc logo

BioCryst Adds $350 Million in New Financing with Royalty Pharma and OMERS Capital Markets

ByQuantisnow·Wall Street's wire, on your screen.
BCRX· BioCryst Pharmaceuticals Inc.RPRX· Royalty Pharma plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCRX (BioCryst Pharmaceuticals Inc.), RPRX (Royalty Pharma plc) and more on Quantisnow.